Synergistic interaction between docosahexaenoic acid and diclofenac on inflammation, nociception, and gastric security models in rats-Reference-Cited by-同舟云学术

Synergistic interaction between docosahexaenoic acid and diclofenac on inflammation, nociception, and gastric security models in rats

Published:2018-08 Issue:5 Volume:79 Page:239-246
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev Res

Author:

Miranda-Lara Christopher Allan¹,Ortiz Mario I.²^ORCID,Rodríguez-Ramos Fernando³,Chávez-Piña Aracely Evangelina¹⁴^ORCID

Affiliation:

1. Maestría en Ciencias en Biomedicina Molecular; Escuela Nacional de Medicina y Homeopatía del Instituto Politécnico Nacional; Ciudad de México Mexico

2. Área Académica de Medicina del Instituto de Ciencias de la Salud; Universidad Autónoma del Estado de Hidalgo; Pachuca, Hidalgo Mexico

3. Departamento de Sistemas Biológicos, División de Ciencias Biológicas y de la Salud; Universidad Autónoma Metropolitana-Xochimilco; Cuidad de México Mexico

4. Laboratorio de Farmacología, Doctorado en Ciencias en Biotecnología; Escuela Nacional de Medicina y Homeopatía del Instituto Politécnico Nacional; Ciudad de México Mexico

Funder

Instituto Politécnico Nacional

Consejo Nacional de Ciencia y Tecnología

Swine Innovation Porc

National Council for Science and Technology

Publisher

Wiley

Subject

Drug Discovery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ddr.21438/fullpdf

Reference46 articles.

1. Advances in NSAID development: Evolution of diclofenac products using pharmaceutical technology;Altman;Drugs,2015

2. Synergistic antinociceptive effect and gastric safety of the combination of docosahexaenoic acid and indomethacin in rats;Arroyo-Lira;Pharmacology Biochemistry and Behavior,2014

3. Supra-additive interaction of docosahexaenoic acid and naproxen and gastric safety on the formalin test in rats;Arroyo-Lira;Drug Development Research,2017

4. Risk of hospitalization with peptic ulcer disease or gastrointestinal hemorrhage associated with nabumetone, Arthrotec((R)), diclofenac, and naproxen in a population based cohort study;Ashworth;The Journal of Rheumatology,2005

5. 17(R)-resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception;Bang;British Journal of Pharmacology,2012

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination Drug Therapy for the Management of Chronic Neuropathic Pain;Biomolecules;2023-12-16

2. Role of antioxidative activity in the docosahexaenoic acid’s enteroprotective effect in the indomethacin-induced small intestinal injury model;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-12-12

3. Montelukast potentiates the antiinflammatory effect of NSAIDs in the rat paw formalin model and simultaneously minimizes the risk of gastric damage;Inflammation Research;2021-08-11

4. Herbal Medicine for Pain Management: Efficacy and Drug Interactions;Pharmaceutics;2021-02-11

5. Synergistic protective effects between docosahexaenoic acid and omeprazole on the gastrointestinal tract in the indomethacin‐induced injury model;Drug Development Research;2020-12-14